US-based pharmaceutical conglomerate AbbVie is set to acquire UK rival Shire in a deal worth $54.5 billion, according to reports.

The two were first reported to have entered merger discussions in early May of this year, though no terms had been reached. Now, reports say the agreed-upon details represents 53 percent …read more

Source: Global Competition Law Blogs